Navigation Links
Emergency response and nanotechnology
Date:7/14/2008

Learning from Past Emergency Response

In a special session running all day Wednesday, presenters will share lessons learned during past incidents involving emergency evacuations, including some involving radiation releases, and the ensuing emergency response (some involving radiation). Presenters use these lessons to model future event responses. One such paper ("Assessment of Emergency Response Planning and Implementation in the Aftermath of Major Natural Disasters and Technological Accidents", Patricia Milligan, pxm@nrc.gov) highlights what has been learned about emergency evacuations: "An important countermeasure in all radiological emergency response plans in the United States is the evacuation of the population in the event of a general emergency condition at a nuclear power plant. In January 2005, the U.S. Nuclear Regulatory Commission (NRC) published its landmark report, "Identification and Analysis of Factors Affecting Emergency Evacuations" (NUREG/CR 6864/), which remains the most comprehensive investigation of public evacuations in the United States in more than 15 years. Data was collected for 230 evacuation incidents, occurring between January 1, 1990 and June 30, 2003. Detailed case studies were prepared for a subset of 50 incidents that were selected based on a profiling and ranking scheme designed to identify evacuation incidents of sufficient complexity to challenge the local and regional emergency response capabilities.

Other highlights in emergency response session:

  • Evacuation or shelter-in-place (Wednesday, 8:45 a.m.)
  • Effectively using measures to mitigate the health effects of radiation exposure (Thursday, 8:45 a.m.)
  • Current capabilities versus what may be needed in a response effort (Wednesday, 9:45 a.m.)
  • Protection of life and property after a radiological dispersal device is activated (Wednesday, 11:45 a.m.)

The Future of Nanotechnology

Beginning at 4:00 p.m. Wednesday afternoon, nanotechnology will be highlighted in a series of presentations designed to increase awareness of new opportunities and challenges. Leading the session will be individuals from Health International Inc. discussing the increased use of nanoparticles having a global exponential impact and revolutionizing nearly every industry: agricultural, chemical, biological, pharmaceutical, medical, electronic, green-energy. This use, however, may pose a health risk for workers and consumers. Nanoscale materials are virtually invisible, yet once inhaled or ingested are able to penetrate and leave deposits on the cell walls of living organs and tissues undetected. Tools and solutions for assessing nanotech and nanoscale materials could be implemented easily based on existing models and methodologies that take into account the delicate balance between security and safety.

Other highlights in the nanotechnology session:

  • The National Institute for Occupational Safety and Health safety plan for working with nanoparticles (Wednesday, 4:15 p.m.)
  • Potential use of nanoparticles as radiopharmaceuticals (Wednesday, 4:30 p.m.)
  • Panel discussion on nanotechnology (Wednesday beginning at 4:45 p.m.)


'/>"/>

Contact: Kelly Classic
media@hps.org
507-254-8444
Health Physics Society
Source:Eurekalert

Related biology news :

1. NASA responds to California wildfire emergency imaging request
2. Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling
3. Triage study challenges notions of emergency medical response to disaster
4. Mitochondrial cholesterol makes response to chemotherapy difficult in hepatic cancer
5. Herceptin and chemo improves response rates without major adverse effects in HER2 breast cancer
6. Yale scientists create artificial cells that boost the immune response to cancer
7. Positron emission tomography superior to standard evaluation tools in measuring treatment response
8. Nonlinear ecosystem response points to environmental solutions
9. Scientists discover a new player in innate immune response
10. Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity
11. 2 genes are important key to regulating immune response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology: